Printer Friendly
The Free Library
4,488,563 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

LTT Bio-Pharma Wins Governmental Backing for Its Collaborative Research on Nonsteroidal Antiinflammatory Drug.


Tokyo, Japan, Aug 4, 2005 - (JCNN JCNN - Japan Corporate News Network) - LTT LTT - Lews Therin Telamon (Wheel of Time series)
LTT - Light Tactical Trailer
LTT - Limited Team Training
LTT - Live Training Transformation (military; set of common components to satisfy live training instrumentation requirements)
LTT - Local Trap Time
LTT - Localized Thermal Therapy
LTT - Long Term Throughput
LTT - Long-Term Training
LTT - Lower Top Tube (bicycles)
LTT - Lunar Transit Telescope
 Bio-Pharma, a Japanese pharmaceutical company specializing in drug delivery systems, announced on August 2 that the Japan Science and Technology Agency (JST JST - Japan Science and Technology Corporation
JST - Japan Standard Time (GMT+0900)
JST - Johnstown, PA, USA - Johnstown Cambria (Airport Code)
JST - Joint Spatio-Temporal Filtering
JST - Joseph Smith Translation
JST - Junior Scratch Tour (youth bowling tour)
JST - JWFC (Joint Warfighting Center) Support Team
) has selected the company's proposal as one of the projects JST supports.

Further, the company and JST signed a three-year contract on August 1. Under this contract, the company, in collaboration with Professor Tohru Mizushima at the Faculty of Medical and Pharmaceutical Sciences, Kumamoto Kumamoto (kmä`mōtō), city (1990 pop. 579,306), capital of Kumamoto prefecture, W Kyushu, Japan. It was an important castle town in the 17th cent.; one of its castles (built 1651) still stands. There are also several shrines in the city. University, will proceed with research on next-generation nonsteroidal non·ster·oid (nn-stîroid, -str-)
adj.
 anti-inflammatory drugs.

Specifically, they aim to develop agents that will be free from developing gastric ulcer and myocardial infarction.

JST will provide the project with a fund of 50 million yen ($450,000) for fiscal 2005.

Source: JCN http://www.japancorp.net

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Aug 5, 2005
Words:133
Previous Article:National Institute of Agrobiological Sciences Successfully Controls Silkworm's Metamorphosis.
Next Article:Kyorin Pharmaceutical to License Its Overactive Bladder Drug to Korean LG Life Sciences.



Related Articles
COX-2 inhibitor pulled off market.(Biomedicine)(Brief Article)
Company pulls pain drug from market.(Pfizer Inc.)(Brief Article)
"Pharma & Bio Ingredients" from Rodman Publications.(Brief Article)
I'rom, LTT Bio-Pharma to Jointly Deploy Anti-aging Business.
I'rom, LTT Bio-Pharma to Establish Joint Venture for Anti-aging Business.
LTT Bio-Pharma Announces Results of Research on Porous Hydroxyapatite Particles.
LTT Bio-Pharma and Others to Co-develop Adhesive Preparation in China.
LTT Bio-Pharma, Jikei University to Jointly Develop Innovative DDS for Steroids.

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles